C1-Inh and heparan sulfate can prevent discordant rejection.
Di Stefano
R
R
Institute of General and Experimental Surgery, CNR, Pisa, Italy.
Frosini
F
F
Scavuzzo
M
M
Ambrogi
M
M
Fagiolini
A
A
Ferrari
M
M
Pelosi
G
G
Mosca
F
F
D000818:Animals; D003174:Complement C1 Inactivator Proteins / Q000627:therapeutic use*; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D006085:Graft Survival / Q000187:drug effects / Q000276:immunology*; D006168:Guinea Pigs; D016027:Heart Transplantation / Q000276:immunology / Q000473:pathology; D006497:Heparan Sulfate / Q000627:therapeutic use*; D008297:Male; D051381:Rats; D011917:Rats, Inbred Lew; D014183:Transplantation, Heterologous / Q000276:immunology* / Q000473:pathology; D016042:Transplantation, Heterotopic
D003174:Complement C1 Inactivator Proteins; D006497:Heparan Sulfate